Search Results - "Goldstein, Julia S."

Phase 3 Trial of Transplantation of Human Islets in Type 1 Diabetes Complicated by Severe Hypoglycemia by Hering, Bernhard J, Clarke, William R, Bridges, Nancy D, Eggerman, Thomas L, Alejandro, Rodolfo, Bellin, Melena D, Chaloner, Kathryn, Czarniecki, Christine W, Goldstein, Julia S, Hunsicker, Lawrence G, Kaufman, Dixon B, Korsgren, Olle, Larsen, Christian P, Luo, Xunrong, Markmann, James F, Naji, Ali, Oberholzer, Jose, Posselt, Andrew M, Rickels, Michael R, Ricordi, Camillo, Robien, Mark A, Senior, Peter A, Shapiro, A M James, Stock, Peter G, Turgeon, Nicole A

“…Impaired awareness of hypoglycemia (IAH) and severe hypoglycemic events (SHEs) cause substantial morbidity and mortality in patients with type 1 diabetes…”
Get full text

Phase 3 trial of human islet‐after‐kidney transplantation in type 1 diabetes by Markmann, James F., Rickels, Michael R., Eggerman, Thomas L., Bridges, Nancy D., Lafontant, David E., Qidwai, Julie, Foster, Eric, Clarke, William R., Kamoun, Malek, Alejandro, Rodolfo, Bellin, Melena D., Chaloner, Kathryn, Czarniecki, Christine W., Goldstein, Julia S., Hering, Bernhard J., Hunsicker, Lawrence G., Kaufman, Dixon B., Korsgren, Olle, Larsen, Christian P., Luo, Xunrong, Naji, Ali, Oberholzer, José, Posselt, Andrew M., Ricordi, Camillo, Senior, Peter A., Shapiro, A. M. James, Stock, Peter G., Turgeon, Nicole A.

“…Allogeneic islet transplant offers a minimally invasive option for β cell replacement in the treatment of type 1 diabetes (T1D). The CIT consortium trial of…”
Get full text

National Institutes of Health-Sponsored Clinical Islet Transplantation Consortium Phase 3 Trial: Manufacture of a Complex Cellular Product at Eight Processing Facilities by Ricordi, Camillo, Goldstein, Julia S, Balamurugan, A N, Szot, Gregory L, Kin, Tatsuya, Liu, Chengyang, Czarniecki, Christine W, Barbaro, Barbara, Bridges, Nancy D, Cano, Jose, Clarke, William R, Eggerman, Thomas L, Hunsicker, Lawrence G, Kaufman, Dixon B, Khan, Aisha, Lafontant, David-Erick, Linetsky, Elina, Luo, Xunrong, Markmann, James F, Naji, Ali, Korsgren, Olle, Oberholzer, Jose, Turgeon, Nicole A, Brandhorst, Daniel, Chen, Xiaojuan, Friberg, Andrew S, Lei, Ji, Wang, Ling-Jia, Wilhelm, Joshua J, Willits, Jamie, Zhang, Xiaomin, Hering, Bernhard J, Posselt, Andrew M, Stock, Peter G, Shapiro, A M James, Chen, Xiaojuan

“…Eight manufacturing facilities participating in the National Institutes of Health-sponsored Clinical Islet Transplantation (CIT) Consortium jointly developed…”
Get full text

Manufacture of Autologous CD34+ Selected Grafts in the NIAID-Sponsored HALT-MS and SCOT Multicenter Clinical Trials for Autoimmune Diseases by Keever-Taylor, Carolyn A., PhD, Heimfeld, Shelly, PhD, Steinmiller, Kaitlyn C., MS, Nash, Richard A., MD, Sullivan, Keith M., MD, Czarniecki, Christine W., PhD, Granderson, Tomeka C, Goldstein, Julia S., MD, Griffith, Linda M., MD, MHS, PhD

“…Abstract To ensure comparable grafts for autologous HCT in NIAID-sponsored IND protocols for multiple sclerosis (HALT-MS) and systemic sclerosis (SCOT), a DMF…”
Get full text

Erratum. National Institutes of Health-Sponsored Clinical Islet Transplantation Consortium Phase 3 Trial: Manufacture of a Complex Cellular Product at Eight Processing Facilities. Diabetes 2016;65:3418-3428 by Ricordi, Camillo, Goldstein, Julia S, Balamurugan, A N, Szot, Gregory L, Kin, Tatsuya, Liu, Chengyang, Czarniecki, Christine W, Barbaro, Barbara, Bridges, Nancy D, Cano, Jose, Clarke, William R, Eggerman, Thomas L, Hunsicker, Lawrence G, Kaufman, Dixon B, Khan, Aisha, Lafontant, David-Erick, Linetsky, Elina, Luo, Xunrong, Markmann, James F, Naji, Ali, Korsgren, Olle, Oberholzer, Jose, Turgeon, Nicole A, Brandhorst, Daniel, Friberg, Andrew S, Lei, Ji, Wang, Ling-Jia, Wilhelm, Joshua J, Willits, Jamie, Zhang, Xiaomin, Hering, Bernhard J, Posselt, Andrew M, Stock, Peter G, Shapiro, A M James

Get full text

Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma by Sullivan, Keith M, Goldmuntz, Ellen A, Keyes-Elstein, Lynette, McSweeney, Peter A, Pinckney, Ashley, Welch, Beverly, Mayes, Maureen D, Nash, Richard A, Crofford, Leslie J, Eggleston, Barry, Castina, Sharon, Griffith, Linda M, Goldstein, Julia S, Wallace, Dennis, Craciunescu, Oana, Khanna, Dinesh, Folz, Rodney J, Goldin, Jonathan, St. Clair, E. William, Seibold, James R, Phillips, Kristine, Mineishi, Shin, Simms, Robert W, Ballen, Karen, Wener, Mark H, Georges, George E, Heimfeld, Shelly, Hosing, Chitra, Forman, Stephen, Kafaja, Suzanne, Silver, Richard M, Griffing, Leroy, Storek, Jan, LeClercq, Sharon, Brasington, Richard, Csuka, Mary E, Bredeson, Christopher, Keever-Taylor, Carolyn, Domsic, Robyn T, Kahaleh, M. Bashar, Medsger, Thomas, Furst, Daniel E

“…Scleroderma is a life-threatening autoimmune disease in need of more effective treatment. A randomized trial of myeloablative therapy followed by autologous…”
Get full text

Purified MHC Class I and Peptide Complexes Activate Naive CD8+ T Cells Independently of the CD28/B7 and LFA-1/ICAM-1 Costimulatory Interactions by Goldstein, Julia S, Chen, Trina, Brunswick, Mark, Mostowsky, Howard, Kozlowski, Steven

“…T cells play a central role in the initiation, maintenance, and regulation of the immune response. Effector responses of T cells are controlled by complex…”
Get full text

ICAM‐1 enhances MHC‐peptide activation of CD8+ T cells without an organized immunological synapse by Goldstein, Julia S., Chen, Trina, Gubina, Elena, Pastor, Richard W., Kozlowski, Steven

“…In addition to the TCR‐ligand interaction, other receptor‐ligand pairs, such as LFA‐1 and ICAM‐1, play a major role in the activation of T cells. Recent…”
Get full text

Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma by Sullivan, Keith M., Goldmuntz, Ellen A., Keyes-Elstein, Lynette, McSweeney, Peter A., Pinckney, Ashley, Welch, Beverly, Mayes, Maureen D., Nash, Richard A., Crofford, Leslie J., Eggleston, Barry, Castina, Sharon, Griffith, Linda M., Goldstein, Julia S., Wallace, Dennis, Craciunescu, Oana, Khanna, Dinesh, Folz, Rodney J., Goldin, Jonathan, St. Clair, E. William, Seibold, James R., Phillips, Kristine, Mineishi, Shin, Simms, Robert W., Ballen, Karen, Wener, Mark H., Georges, George E., Heimfeld, Shelly, Hosing, Chitra, Forman, Stephen, Kafaja, Suzanne, Silver, Richard M., Griffing, Leroy, Storek, Jan, LeClercq, Sharon, Brasington, Richard, Csuka, Mary E., Bredeson, Christopher, Keever-Taylor, Carolyn, Domsic, Robyn T., Kahaleh, M. Bashar, Medsger, Thomas, Furst, Daniel E.

Get full text

Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis by Georges, George E., Cohen, Jeffrey A, Griffith, Linda M., Steinmiller, Kati, Barry, Bill, Harris, Kristina, Ryker, Kristin, Rice, Janis, Tosta, Patti, McCarthy, Sean, Goldstein, Julia S, McNamara, James, Miller, Deborah, Carlson, Joshua J, Arnold, Douglas L, Smilek, Dawn E, Muraro, Paolo A.

“…Myeloablative and immunoablative therapy followed by autologous hematopoietic stem cell transplantation (AHSCT) has been shown to be effective in patients with…”
Get full text

ICAM‐1 co‐stimulation has differential effects on the activation of CD4+ and CD8+ T cells by Chen, Trina, Goldstein, Julia S., O'Boyle, Kevin, Whitman, Mary C., Brunswick, Mark, Kozlowski, Steven

“…T cells play a central role in the initiation, maintenance and regulation of the immune response. Effector responses of T cells are controlled by complex…”
Get full text